Shore-Lesserson L, Baker RA, Ferraris V, Greilich PE, Fitzgerald D, Roman P, et al. STS/SCA/ AmSECT clinical practice guidelines: anticoagulation during cardiopulmonary bypass. J Extra Corpor Technol. 2018;50:5–18.

Article  PubMed  PubMed Central  Google Scholar 

Levy JH, Connors JM. Heparin resistance-clinical perspectives and management strategies. N Engl J Med. 2021;385:826–32.

Article  CAS  PubMed  Google Scholar 

Panicucci F, Sagripanti A, Conte B, Pinori E, Vispi M, Lecchini L. Antithrombin III, heparin cofactor and antifactor Xa in relation to age, sex and pathological condition. Haemostasis. 1980;9:297–302.

CAS  PubMed  Google Scholar 

Kawatsu S, Sasaki K, Sakatsume K, Takahara S, Hosoyama K, Masaki N, et al. Predictors of heparin resistance before cardiovascular operations in adults. Ann Thorac Surg. 2018;105:1316–21.

Article  PubMed  Google Scholar 

Yamashiro T, Hibiya M, Takagi Y. Study on influencing. factors on heparin reactivity. Jpn J Extra-Corpor Technol. 2020;47:115–21.

Google Scholar 

Yamashiro T, Takami Y, Takagi Y. Contributing factors to heparin resistance during cardiopulmonary bypass. J Artif Organs. 2024. https://doi.org/10.1007/s10047-024-01435-1.

Article  PubMed  Google Scholar 

Hogwood J, Mulloy B, Lever R, Gray E, Page CP. Pharmacology of heparin and related drugs: an update. Pharmacol Rev. 2023;75:328–79.

Article  CAS  PubMed  Google Scholar 

Casu B, Oreste P, Torri G, Zoppetti G, Choay J, Lormeau JC, et al. The structure of heparin oligosaccharide fragments with high anti-factor Xa activity containing the minimal antithrombin III-binding sequence. chemical and 13C nuclear-magnetic-resonance studies. Biochem J. 1981;197:599–609.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choay J, Petitou M, Lormeau JC, Sinay P, Casu B, Gatti G. Structure-activity relationship in heparin: a synthetic penta- saccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochem Biophys Res Commun. 1983;116:492–9.

Article  CAS  PubMed  Google Scholar 

Lindahl U, Thunberg L, Bäckström G, Riesenfeld J, Nordling K, Björk I. Extension and structural variability of the antithrombin-binding sequence in heparin. J Biol Chem. 1984;259:12368–76.

Article  CAS  PubMed  Google Scholar 

Atha DH, Lormeau JC, Petitou M, Rosenberg RD, Choay J. Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III. Biochemistry. 1987;26:6454–61.

Article  CAS  PubMed  Google Scholar 

Danielsson A, Raub E, Lindahl U, Björk I. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. J Biol Chem. 1986;261:15467–73.

Article  CAS  PubMed  Google Scholar 

Tollefsen DM, Majerus DW, Blank MK. Heparin cofactor II. purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. J Biol Chem. 1982;257:2162–9.

Article  CAS  PubMed  Google Scholar 

Huang ZF, Wun T-C, Broze GJ. Kinetics of factor Xa inhibition by tissue factor. pathway inhibitor. J Biol Chem. 1993;268:26950–5.

Article  CAS  PubMed  Google Scholar 

Ito K, Sasaki K, Ono M, Saiki Y, et al. Investigation of real-world heparin resistance and anticoagulation management prior to cardiopulmonary bypass: report from a nationwide survey by the Japanese association for thoracic Surgery heparin resistance working group. Gen Thorac Cardiovasc Surg. 2024;72:8–14.

Article  PubMed  Google Scholar 

Dirkmann D, Nagy E, Britten MW, Peters J. Point-of-care measurement of activated clotting time for cardiac surgery as measured by the hemochron signature elite and the abbott i-STAT: agreement, concordance, and clinical reliability. BMC Anesthesiol. 2019;19:174.

Article  PubMed  PubMed Central  Google Scholar 

Wehner JE, Boehne M, David S, Brand K, Tiede A, Bikker R. Activated clotting time (act) for monitoring of low-dose heparin: performance characteristics in healthy adults and critically ill patients. Clin Appl Thromb Hemost. 2020;26:1076029620975494.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sniecinski RM, Bennett Guerrero E, Shore LL. Anticoagulation. management and heparin resistance during cardiopulmonary bypass: a survey of society of cardiovascular anesthesiologists members. Anesth Analg. 2019;129:e41–4.

Article  CAS  PubMed  Google Scholar 

Mitchell GA, Hudson PM, Huseby RM, Pochron SP, Gargiulo RJ. Fluorescent substrate assay for antithrombin III. Thromb Res. 1978;12:219–25.

Article  CAS  PubMed  Google Scholar 

Miike T, Sakamoto Y, Inoue S. Influence of high-dose antithrombin on platelet function and blood coagulation. Acute Med Surg. 2021;8: e648.

Article  PubMed  PubMed Central  Google Scholar